Zinc Alters Gut Microbiota, Cuts Resistance to C. difficile

This article originally appeared here.
Share this content:
Zinc Alters Gut Microbiota, Cuts Resistance to <i>C. difficile</i>
Zinc Alters Gut Microbiota, Cuts Resistance to C. difficile

FRIDAY, Oct. 7, 2016 (HealthDay News) -- Dietary zinc (Zn) alters the gut microbiota and affects resistance to Clostridium difficile infection (CDI), according to research published online Sept. 26 in Nature Medicine.

Noting that unexplored environmental, nutrient, and host factors likely influence CDI, Joseph P. Zackular, Ph.D., from Vanderbilt University School of Medicine in Nashville, Tenn., and colleagues examined the impact of dietary zinc on CDI.

The researchers found that excess dietary Zn altered the gut microbiota and reduced the minimum amount of antibiotics necessary to confer susceptibility to CDI. Excess dietary Zn severely exacerbated C. difficile-associated disease in mice colonized with C. difficile by increasing toxin activity and changing the host immune response. The Zn-binding S100 protein calprotectin was a key element of the innate immune response to CDI and also had antimicrobial effects against C. difficile.

"These data suggest that nutrient Zn levels have a key role in determining susceptibility to CDI and severity of disease, and that calprotectin-mediated metal limitation is an important factor in the host immune response to C. difficile," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

More U.S. Teens Are Vaping, but Use of Opioids, Alcohol Falling

More U.S. Teens Are Vaping, but Use of ...

About 37 percent of 12th graders said they had vaped within the previous 12 months

Type 2 Diabetes Risk Lower in Women With Active Migraine

Type 2 Diabetes Risk Lower in Women With ...

Prevalence of active migraine decreased linearly in the 24 years prior to diabetes diagnosis

Buprenorphine-Naloxone Cost-Effective for Opioid Use Disorder

Buprenorphine-Naloxone Cost-Effective for Opioid Use Disorder

Treatment costs less than extended-release naltrexone without negative impact on outcomes

is free, fast, and customized just for you!




Already a member?

Sign In Now »